Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

With semaglutide and tirzepatide dosed once weekly, their estimated average yearly costs in the U.S. are $14,080 and $8,126, ...

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, ...

Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

Some individuals living with obesity and overweight may find it difficult to embark on a weight loss journey alone. It’s not ...

There is new guidance on the use of popular weight loss medications like Zepbound and Wegovy to help improve heart health.

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

Dr. Tara Narula takes a look at weight-loss medications and how entire families can benefit when one person starts taking the drugs.

If you’re considering using medication to reach a healthy body weight, your first question might be: Are weight loss drugs covered by insurance? The short answer: Sometimes, but not always.